Seroprevalence of Antibodies to Measles, Mumps and Rubella in Thai Adolescents
Phase 1
- Conditions
- Measles diseaseMumps diseaseRubella diseaseSeroprevelenceMeaslesMumpsRubellaThaiAdolescents
- Registration Number
- TCTR20191120001
- Lead Sponsor
- Center of Excellence for Pediatric Infectious Disease and Vaccine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending (Not yet recruiting)
- Sex
- All
- Target Recruitment
- 450
Inclusion Criteria
Informed consents
Unremarkable medical history and physical examination
Exclusion Criteria
Immunocompromised host
Received MMR vaccination after aged of 7 years
Received blood product within 3 months
Received immunosuppressive agents within 3 months
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Seroprevalence of Antibodies to Measles Virus in adolescents 1 month after complete recruitment Measles antibody by Elisa test
- Secondary Outcome Measures
Name Time Method Seroprevalence of Antibodies to Mumps and Rubella Virus in adolescents 1 month after complete recruitment Mumps and Rubella antibody by Elisa test